deaths (OS)progression or deaths (PFS)RFS/DFS

non squamous - mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) non squamous cell - mNSCLC - L2 non squamous - mNSCLC - L2 - all population

versus docetaxel
nivolumab alone vs. docetaxel 1 0.73 [0.59; 0.90], 1 RCT, I2=0% conclusive
unassessable degree of certainty
0.92 [0.77; 1.10], 1 RCT, I2=0%
inconclusive result
-